Crawford & Company A (CRD.A)
NYSE:CRD.A
Top Page
Crawford & Company A
(NYSE:CRD.A)
Select Model
Select Model
Rating:58Neutral
Price Target:
$9.50
▼(-8.83% Downside)
Action:ReiteratedDate:03/03/26
The score reflects mixed financial performance—thin and volatile earnings with elevated leverage—partly offset by stronger recent cash flow. Technicals are neutral-to-slightly positive with the stock above key moving averages but limited momentum confirmation. Valuation is reasonable with a mid-range P/E and a moderate dividend yield.
Positive Factors
Operating cash flow rebound
Consistent and improving operating cash flow provides durable liquidity to fund operations, service debt, and invest without immediate capital raises. The 2025 rebound strengthens near-term financial flexibility and lowers refinancing pressure, supporting resilience across a 2–6 month horizon.
Negative Factors
Elevated leverage
Debt-to-equity around 2x materially limits financial flexibility and raises interest cost sensitivity. With a relatively modest equity base, elevated leverage leaves less room for operational shocks or opportunistic investments and increases refinancing and solvency risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Operating cash flow rebound
Consistent and improving operating cash flow provides durable liquidity to fund operations, service debt, and invest without immediate capital raises. The 2025 rebound strengthens near-term financial flexibility and lowers refinancing pressure, supporting resilience across a 2–6 month horizon.
Read all positive factors
Crawford & Company A (CRD.A) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$502.43M
Dividend Yield2.47%
Average Volume (3M)56.86K
Price to Earnings (P/E)―
Beta (1Y)1.09
Revenue Growth4.39%
EPS Growth61.61%
CountryUS
Employees9,134
SectorFinancial
Sector Strength70
IndustryInsurance - Brokers
Share Statistics
EPS (TTM)0.15
Shares Outstanding29,688,044
10 Day Avg. Volume59,347
30 Day Avg. Volume56,858
Financial Highlights & Ratios
PEG Ratio-1.10
Price to Book (P/B)3.22
Price to Sales (P/S)0.43
P/FCF Ratio6.01
Enterprise Value/Market Cap1.46
Enterprise Value/Revenue0.56
Enterprise Value/Gross Profit2.27
Enterprise Value/Ebitda7.90
Forecast
1Y Price Target
$14.00Price Target Upside34.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.05
Revenue Forecast (FY)$1.34B
Crawford & Company A Business Overview & Revenue Model
Company Description
Crawford & Company provides claims management and outsourcing solutions for carriers, brokers, and corporations in the United States, the United Kingdom, Europe, Canada, Australia, and internationally. The company's Crawford Loss Adjusting provide...
How the Company Makes Money
null...
Crawford & Company A Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
44
Neutral
Cash Flow
68
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.31B | 1.34B | 1.32B | 1.23B | 1.14B |
| Gross Profit | 321.90M | 367.55M | 359.07M | 306.35M | 291.80M |
| EBITDA | 92.62M | 97.61M | 102.91M | 52.11M | 91.02M |
| Net Income | 19.63M | 26.60M | 30.61M | -18.30M | 30.69M |
Balance Sheet | |||||
| Total Assets | 764.30M | 803.75M | 799.20M | 791.51M | 852.64M |
| Cash, Cash Equivalents and Short-Term Investments | 64.08M | 55.41M | 58.36M | 46.01M | 53.23M |
| Total Debt | 270.27M | 309.49M | 311.53M | 346.40M | 288.67M |
| Total Liabilities | 592.87M | 648.20M | 659.37M | 668.13M | 641.24M |
| Stockholders Equity | 173.09M | 157.21M | 141.62M | 124.54M | 211.97M |
Cash Flow | |||||
| Free Cash Flow | 92.81M | 9.97M | 67.19M | -6.96M | 23.37M |
| Operating Cash Flow | 101.85M | 51.62M | 103.79M | 27.63M | 54.32M |
| Investing Cash Flow | -36.21M | -41.65M | -36.60M | -57.88M | -70.83M |
| Financing Cash Flow | -57.62M | -12.86M | -54.68M | 25.94M | 24.66M |
Crawford & Company A Technical Analysis
Neutral
10.42
Price Trends
10.30
Positive
10.65
Negative
10.56
Negative
Market Momentum
0.07
Negative
56.84
Neutral
84.18
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CRD.A, the sentiment is Neutral. The current price of 10.42 is above the 20-day moving average (MA) of 9.89, above the 50-day MA of 10.30, and below the 200-day MA of 10.56, indicating a neutral trend. The MACD of 0.07 indicates Negative momentum. The RSI at 56.84 is Neutral, neither overbought nor oversold. The STOCH value of 84.18 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CRD.A.
Crawford & Company A Risk Analysis
Crawford & Company A disclosed 24 risk factors in its most recent earnings report. Crawford & Company A reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Crawford & Company A Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
58 Neutral | $502.43M | -19.26 | 11.25% | 2.47% | 4.39% | 61.61% | |
58 Neutral | $115.58M | 0.95 | 13.52% | ― | 13.16% | ― | |
55 Neutral | $41.02M | 3.50 | 4.33% | ― | 16.79% | ― | |
53 Neutral | $502.43M | 28.40 | 11.25% | 2.47% | 4.39% | 61.61% | |
43 Neutral | $30.14M | -0.21 | -158.66% | ― | 7.56% | -344.04% |
* Financial Sector Average
CRD.A
Crawford & Company A
10.42
0.38
3.73%
EHTH
Ehealth
1.32
-4.82
-78.50%
CRD.B
Crawford & Company B
10.17
0.24
2.43%
SLQT
SelectQuote
0.66
-2.51
-79.27%
GOCO
GoHealth
1.05
-9.40
-89.99%
Crawford & Company A Corporate Events
Business Operations and StrategyExecutive/Board ChangesShareholder Meetings
Crawford & Company Names Bruce Swain Permanent CEO
Positive
Mar 23, 2026
Crawford Company, a global claims management and outsourcing provider to insurers and self-insured organizations, operates from its Atlanta headquarters with an extensive network in over 70 countries and dual share classes that separate voting ri...
Business Operations and StrategyFinancial Disclosures
Crawford & Company A Reports Mixed 2025 Financial Performance
Negative
Mar 2, 2026
Crawford Company reported on March 2, 2026 that its fourth-quarter 2025 revenues before reimbursements fell 11% year-on-year to $308.5 million, resulting in a net loss of $7.2 million after a prior-year profit, while full-year 2025 revenues dippe...
Business Operations and StrategyExecutive/Board Changes
Crawford & Company adopts new global operating structure
Positive
Jan 21, 2026
On January 21, 2026, Crawford Company announced that, effective January 1, 2026, it adopted a new global operating structure built around two divisions, U.S. Operations and International Operations, to simplify its organization and sharpen its cl...
Business Operations and StrategyExecutive/Board Changes
Crawford & Company Appoints New CEO for U.S. Operations
Positive
Jan 15, 2026
On January 14, 2026, Crawford Company entered into a new executive employment agreement with Michael J. Hoberman in connection with his promotion to CEO – US Operations, effective January 1, 2026. The agreement outlines a compensation packa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.